Dotquant LLC
Shoreline, WA
- UEI
- HPN4P84J65F7
- CAGE
- 6ZGY5
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- SAM.gov registration date
- Physical address
- 2907 NE 196th St, Shoreline, WA 98155, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a WT rnap-based kit for high-yield synthesis of chemically modified RNA - abstract with the growing… | National Institute of General Medical Sciences | $305,892 | |
| Sbir PA22-176 - RNA aptamers for rapid response to covid-19 variants | Office of Financial Resources | $550,964 | |
| Developing a sensitive and quantitative western blot kit - abstract western blotting is one of the most widely used… | National Institute of General Medical Sciences | $767,020 | |
| In situ single cell imaging | National Cancer Institute | $2,639,194 | |
| Genetic engineering RGD-containing sirna protein carrier | National Institute of Biomedical Imaging and Bioenginering | $734,987 |
About Dotquant LLC
Dotquant LLC is a for-profit limited liability company registered in SAM.gov since September 2013, with its registration set to expire in December 2025. The company appears to be a biotechnology-focused research and development organization that develops innovative scientific research tools and technologies, with a particular emphasis on molecular biology and biomedical applications. Based on its federal grant award history, Dotquant LLC specializes in creating advanced research kits and technologies that address critical challenges in scientific research, particularly in areas involving RNA, protein analysis, and biotechnological innovations.
The company has secured multiple federal grants from civilian agencies, primarily the National Institute of General Medical Sciences (NIGMS) and the Office of the Director, focusing on developing cutting-edge scientific research technologies. Its recent grant awards include a $305,892 project grant to develop an advanced in vitro transcription kit for high-yield synthesis of chemically modified RNA, which aims to improve RNA drug affordability and research capabilities. Another grant involved developing RNA aptamers for rapid response to COVID-19 variants, demonstrating the company's ability to address urgent scientific challenges. A previous grant supported the development of a sensitive and quantitative Western blot kit designed to enhance protein detection and quantification techniques. These projects indicate Dotquant LLC's expertise in molecular biology, biotechnology research, and the creation of advanced scientific research tools that have potential applications in medical research, drug development, and diagnostic technologies.
Quick answers
What is Dotquant LLC's UEI?
Dotquant LLC's Unique Entity ID (UEI) in SAM.gov is HPN4P84J65F7.
What is Dotquant LLC's CAGE code?
Dotquant LLC's CAGE code is 6ZGY5.
Where is Dotquant LLC located?
Dotquant LLC's physical address in SAM.gov is 2907 NE 196th St, Shoreline, WA 98155, USA.
Is Dotquant LLC registered in SAM.gov?
Yes. Dotquant LLC's SAM.gov registration is active through December 14, 2026.
What is Dotquant LLC's most recent federal award?
Dotquant LLC's most recent federal grant award is Development of a WT rnap-based kit for high-yield synthesis of chemically modified RNA - abstract with the growing… (R43GM151884), from National Institute of General Medical Sciences, on August 10, 2024.
On GovTribe
See Dotquant LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors